5 Key Findings to Becoming a Great Scientific Mentor with Riley Elmer
In this 36‑minute episode, host Riley Elmer breaks down five essential principles for effective scientific mentorship, emphasizing the importance of aligning values, seeking mentors beyond just technical expertise, and using productive tension to foster growth. He shares personal anecdotes that illustrate how the right mentor can shape career trajectories in both academia and industry. The discussion offers practical guidance for graduate students and early‑career researchers on selecting and cultivating mentor‑mentee relationships. Overall, the episode underscores mentorship as a strategic tool for long‑term career development.
Tissue Engineering
The winners from NASA’s Vascular Tissue Challenge are taking their Earth-based research to space.
A Billion Dollar Bet on AI-First Drug Development
In this episode, Marc Tessier‑Lavigne, co‑founder and CEO of Xaira, explains how the company is using an end‑to‑end AI platform to overhaul drug discovery by tackling three core bottlenecks: target selection, molecule design, and patient stratification. Xaira trains high‑dimensional "virtual...
E202: Recent Advances in LLMs and How They Will Impact Science and Pharma Research
In this episode, Javier Tordable, founder and CEO of Pauling.ai and former Google technologist, explains how modern large language models have evolved into autonomous AI agents capable of executing multi‑step scientific workflows, from literature synthesis to hypothesis generation and computational...
GLP Podcast: Everybody’s Wrong About RFK, Jr.’s Dietary Guidelines
In this episode, Dr. Liza Lockwood and Cameron J. English dissect the new Dietary Guidelines for Americans, which promote "real food"—full‑fat dairy, fruits, vegetables, and more protein—while still limiting saturated fat to under 10% of calories. They explain how media...
Finding New Targets on the Surface of Misfolded Proteins
In this episode of The Bio Report, host and guests discuss Immuto Scientific’s novel approach to drug discovery that targets disease‑specific protein conformations rather than genetic sequences. CEO Faraz Choudhury explains how the company’s AI‑driven structural surfaceomics platform maps the...
E201: The Small Molecule Revolution: ProPhet's Tom Shani on AI-Powered Drug Discovery
In this episode, Tom Shani, CEO and co‑founder of ProPhet, explains how AI—particularly machine learning models, transformers, and novel molecular representations—is transforming small‑molecule drug discovery by tackling slow timelines, high failure rates, and massive R&D costs. He shows how AI...
Inside MUTU System: Clinical Validation, Real Outcomes, and a Global Mission to Transform Core & Pelvic Health for Women
In this episode, Wendy Powell, founder of the MUTU System, discusses how her digitally delivered pelvic health platform achieved clinical validation and delivers measurable improvements in core and pelvic floor function for women. She explains the rigorous validation process, the...
An Effort to Detect and Treat Alzheimer’s at Its Earliest Stages
In this episode, Daniel Levine interviews Valerie Daggett, founder and CEO of AltPep, about the company's strategy to detect and treat Alzheimer's disease at its earliest stage by targeting toxic α‑sheet oligomers with synthetic peptide therapeutics and companion diagnostics. Daggett...
From One Voice to Many: Gabriella Rubert, Riley Conover Elmer & Karishma Chhugani
Gabriella Rubert reflects on her tenure as host of the Inside Biotech podcast, discussing the challenges of translating complex science into engaging stories and the responsibility that comes with science communication. She emphasizes the power of storytelling to bridge biotech...
A Year of Biotech Bytes: The Stories, Lessons, and Laughs Behind the Mic
In this retrospective episode, host and guest Mary Louise Smith reflect on Biotech Bytes' first year, sharing how the podcast began, the power of simple conversations for generating ideas, and the role of AI in streamlining work. Mary offers behind‑the‑scenes...
844: Applying Physics and Nanotechnology to Understand Mechanics and Shape in Biological Systems - Dr. Sonia Contera
In this episode, Dr. Sonia Contera discusses how physics and nanotechnology can illuminate the mechanics and shape of biological systems, from molecular assemblies to whole organs. She explains her interdisciplinary approaches—such as nanoscale imaging and mechanical probing—to study pancreatic tumors,...
GLP Podcast: Evolutionary Mismatch. Is Civilization Wrecking Our Health?
The episode examines the evolutionary mismatch theory, arguing that modern industrialized life bombards humans with chronic low‑level stressors unlike the intermittent challenges faced by our hunter‑gatherer ancestors, leading to physical ailments such as hypertension, immune decline, and reduced fertility, as...
Editors’ Choice: Top Stories of 2025
In the year‑end episode, GEN editors review six headline biotech stories, highlighting AI’s expanding role in drug discovery, a landmark success for Baby KJ in cell‑gene therapy, and the turbulent year for Sarepta’s DMD gene therapy Elevidys, including patient deaths...
GLP Podcast: Ketamine—Miracle Depression Treatment, or Recreational Nightmare?
The episode examines ketamine’s rise from a battlefield anesthetic to an FDA‑approved treatment (esketamine) for treatment‑resistant depression, highlighting its rapid antidepressant effects and potential to reduce suicidal thoughts. Experts discuss the drug’s significant risks—including addiction, dissociation, blood‑pressure spikes, bladder damage,...
Determining the Cause and Severity of Sepsis with a Point-of-Care Test
In this episode of The Bio Report, host Daniel Levine interviews Tim Sweeney, CEO of Inflammatix, about the company's TriVerity point‑of‑care test that rapidly distinguishes bacterial from viral infections and gauges immune response severity in sepsis patients. Sweeney explains how...